Literature DB >> 16440414

CD44v6 in peripheral blood and bone marrow of patients with gastric cancer as micro-metastasis.

Dao-Rong Wang1, Guo-Yu Chen, Xun-Liang Liu, Yi Miao, Jian-Guo Xia, Lin-Hai Zhu, Dong Tang.   

Abstract

AIM: To detect the expression of CD44 correlated with the ability of micro-metastasis in peripheral blood and bone marrow of patients with gastric cancer and to deduce its clinical significance.
METHODS: Preoperative peripheral blood and bone marrow specimens from 46 patients with gastric cancer and 6 controls were studied by semi-quantitative RT-PCR amplification of CD44v6mRNA. Preoperative and postoperative peripheral blood specimens from 40 patients with gastric cancer and 14 controls were studied by quantitative RT-PCR amplification of CD44v6mRNA in the corresponding period.
RESULTS: Semi-quantitative RT-PCR amplification showed that CD44v6mRNA expression of peripheral blood and bone marrow was positive in 39 (84.8%) and 40 (86.9%) of 46 patients with gastric cancer, respectively. In peripheral blood, CD44v6mRNA expression was positive for diffuse type in 30 (93.8%) of 32 patients and for intestinal type in 9 (64.3%) of 14 patients. On the other hand, in bone marrow, CD44v6mRNA expression was positive for diffuse type in 31 (96.9%) of 32 patients and for intestinal type in 10 (71.4%) of 14 patients. There was a significant difference between the diffuse type and intestinal type. Quantitative RT-PCR amplification demonstrated that CD44v6mRNA was not expressed in the peripheral blood of controls and CD44v6mRNA expression was positive for preoperative peripheral blood in 40 patients with gastric cancer, the expression levels being from 4.9 x 10(8) - 3.2 x 10(11) copies/g RNA. The average expression level of CD44v6mRNA in peripheral blood was 3.9 x 10(10) copies/g RNA. The expression levels of CD44v6mRNA in peripheral blood in gastric cancer patients after curative operation increased from 5.5 x 10(6) to 7.6 x 10(9) copies/g RNA and the average level was 2.4 x 10(8) copies/g RNA (Figure 3B) (P = 0.00496). After curative operation, the expression level decreased markedly.
CONCLUSION: Semi-quantitative and quantitative RT-PCR amplification for CD44v6mRNA is a sensitive and specific method for the detection of micro-metastasis in peripheral blood and bone marrow, which might be used as an indicator of tumor burden and therapeutic effect.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16440414      PMCID: PMC4077475          DOI: 10.3748/wjg.v12.i1.36

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  22 in total

1.  [A multianalysis study on clinicopathologic factors related to lymph node metastasis in gastric cancer].

Authors:  S Zhang; L Li; H Lin
Journal:  Zhonghua Zhong Liu Za Zhi       Date:  2001-09

Review 2.  CD44 and its partners in metastasis.

Authors:  Serge Jothy
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

3.  Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.

Authors:  Mee Joo; Hye Kyung Lee; Yun Kyung Kang
Journal:  Anticancer Res       Date:  2003 Mar-Apr       Impact factor: 2.480

4.  A novel method for real time quantitative RT-PCR.

Authors:  U E Gibson; C A Heid; P M Williams
Journal:  Genome Res       Date:  1996-10       Impact factor: 9.043

5.  CD44V6 in gastric carcinoma: a marker of tumor progression.

Authors:  Y Xin; A Grace; M M Gallagher; B T Curran; M B Leader; E W Kay
Journal:  Appl Immunohistochem Mol Morphol       Date:  2001-06

6.  Expression of CD44v6 in advanced gastric cancer and its relationship to hematogenous metastasis and long-term prognosis.

Authors:  Akio Yamaguchi; Takanori Goi; Jiren Yu; Yasuo Hirono; Makoto Ishida; Atsushi Iida; Toshihisa Kimura; Kazuo Takeuchi; Kanji Katayama; Kazuo Hirose
Journal:  J Surg Oncol       Date:  2002-04       Impact factor: 3.454

7.  Expression of proliferating cell nuclear antigen and CD44 variant exon 6 in primary tumors and corresponding lymph node metastases of colorectal carcinoma with Dukes' stage C or D.

Authors:  Ji-Cheng Zhang; Zuo-Ren Wang; Yan-Juan Cheng; Ding-Zhong Yang; Jing-Sen Shi; Ai-Lin Liang; Ning-Na Liu; Xiao-Min Wang
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

8.  Application of RT-PCR to clinical diagnosis of micrometastasis of colorectal cancer: A translational research study.

Authors:  Osamu Takayama; Hirofumi Yamamoto; Kimimasa Ikeda; Hideyuki Ishida; Takeshi Kato; Masaki Okuyama; Toshiyuki Kanou; Mutsumi Fukunaga; Shusei Tominaga; Shunji Morita; Yujiro Fujie; Hiroki Fukunaga; Masakazu Ikenaga; Masataka Ikeda; Masayuki Ohue; Mitsugu Sekimoto; Nobuteru Kikkawa; Morito Monden
Journal:  Int J Oncol       Date:  2004-09       Impact factor: 5.650

9.  CD44v6: a potential marker of malignant transformation in intestinal metaplasia of the stomach? An immunohistochemical study using tissue microarrays.

Authors:  Christian Gulmann; Antoinette Grace; Mary Leader; David Butler; Stephen Patchett; Elaine Kay
Journal:  Eur J Gastroenterol Hepatol       Date:  2003-09       Impact factor: 2.566

10.  Monoclonal antibodies to human lymphocyte homing receptors define a novel class of adhesion molecules on diverse cell types.

Authors:  L J Picker; M Nakache; E C Butcher
Journal:  J Cell Biol       Date:  1989-08       Impact factor: 10.539

View more
  5 in total

1.  Low-dose interleukin-8 induces the adhesion, migration and invasion of the gastric cancer SGC-7901 cell line.

Authors:  Jun Shi; Pin-Kang Wei
Journal:  Oncol Lett       Date:  2015-08-25       Impact factor: 2.967

2.  Expression of cell adhesion molecule CD44 in gastric adenocarcinoma and its prognostic importance.

Authors:  Kamran Ghaffarzadehgan; Mostafa Jafarzadeh; Hamid Reza Raziee; Hamid Reza Sima; Ehsan Esmaili-Shandiz; Hanieh Hosseinnezhad; Ali Taghizadeh-Kermani; Omeed Moaven; Maryam Bahrani
Journal:  World J Gastroenterol       Date:  2008-11-07       Impact factor: 5.742

3.  The Role of CD44 in the Pathogenesis, Diagnosis, and Therapy of Gastric Cancer.

Authors:  Byung Ik Jang; Yuan Li; David Y Graham; Putao Cen
Journal:  Gut Liver       Date:  2011-11-21       Impact factor: 4.519

4.  Engineering of lipid prodrug-based, hyaluronic acid-decorated nanostructured lipid carriers platform for 5-fluorouracil and cisplatin combination gastric cancer therapy.

Authors:  Chun-Ying Qu; Min Zhou; Ying-wei Chen; Mei-mei Chen; Feng Shen; Lei-Ming Xu
Journal:  Int J Nanomedicine       Date:  2015-06-10

5.  Bone Metastasis From Gastric Adenocarcinoma-What Are the Risk Factors and Associated Survival? A Large Comprehensive Population-Based Cohort Study.

Authors:  Lei Huang; Yajie Zhao; Yan Shi; Weiguo Hu; Jun Zhang
Journal:  Front Oncol       Date:  2022-03-25       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.